Natlawreview
Published October 5, 2026
PharmaTher Outlines Corporate Strategy and Upcoming Milestones; L
Read the full story at Natlawreview
First proprietary 503A peptide products are planned for Q4 2026, followed by a ketamine dissolvable tablet for telehealth in Q1 2027. Rare pediatric.
Surfaced by 3 Google Alerts
- Ketamine
- Psychedelics
- Psychedelic press release